F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
Last updated: 2026-07-27 01:35:46 ET
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK JrA panel of federal health advisers ...
Edinburgh-based tech firm Craneware said customer data was stolen during a cyberattack. The company makes software that thousands of U.S. hospitals, p...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE